These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 19219959)

  • 21. The Chinese free antiretroviral treatment program: challenges and responses.
    Zhang F; Haberer JE; Wang Y; Zhao Y; Ma Y; Zhao D; Yu L; Goosby EP
    AIDS; 2007 Dec; 21 Suppl 8():S143-8. PubMed ID: 18172383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiretroviral rounds. Should we mess with success?
    J Watch AIDS Clin Care; 2009 Aug; 21(8):63-5. PubMed ID: 19795534
    [No Abstract]   [Full Text] [Related]  

  • 23. One as potent as five.
    Susman E
    AIDS; 2002 Aug; 16(12):N7. PubMed ID: 12214591
    [No Abstract]   [Full Text] [Related]  

  • 24. Nucleoside reverse transcriptase inhibitor-sparing regimen (nonnucleoside reverse transcriptase inhibitor + protease inhibitor) was more likely associated with resistance comparing to nonnucleoside reverse transcriptase inhibitor or protease inhibitor + nucleoside reverse transcriptase inhibitor in the randomized ANRS 121 trial.
    Soulié C; Assoumou L; Ghosn J; Duvivier C; Peytavin G; Ait-Arkoub Z; Molina JM; Costagliola D; Katlama C; Calvez V; Marcelin AG
    AIDS; 2009 Jul; 23(12):1605-8. PubMed ID: 19487903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structured treatment interruption.
    Boyle BA
    AIDS Read; 2000 May; 10(5):259-62. PubMed ID: 10851712
    [No Abstract]   [Full Text] [Related]  

  • 26. Antiretroviral rounds. CD4 count 423, viral load 12,000: time to treat anyway?
    Hodder S; Frank I
    AIDS Clin Care; 2006 Jun; 18(6):59-60. PubMed ID: 16791955
    [No Abstract]   [Full Text] [Related]  

  • 27. Inadvertent non-nucleoside reverse transcriptase inhibitor (NNRTI)-based antiretroviral therapy in dual HIV-1/2 and HIV-2 seropositive West Africans: a retrospective study.
    Sarfo FS; Bibby DF; Schwab U; Appiah LT; Clark DA; Collini P; Phillips R; Green I; Dittmar MT; Chadwick DR
    J Antimicrob Chemother; 2009 Sep; 64(3):667-9. PubMed ID: 19549668
    [No Abstract]   [Full Text] [Related]  

  • 28. Anti-HIV agents. Different effects of nukes in men and women.
    TreatmentUpdate; 2000 Sep; 12(6):1-2. PubMed ID: 12132458
    [No Abstract]   [Full Text] [Related]  

  • 29. Tamoxifen in antiretroviral-associated gynaecomastia.
    Kegg S; Lau R
    Int J STD AIDS; 2002 Aug; 13(8):582-3. PubMed ID: 12194746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. When to start antiretroviral therapy? NA-ACCORD stimulates the debate.
    Gallant JE
    AIDS Read; 2009 Feb; 19(2):49-50, 61. PubMed ID: 19271328
    [No Abstract]   [Full Text] [Related]  

  • 31. Antiretroviral suppression of HIV in the context of persistently low CD4 counts: new insights.
    Laurence J
    AIDS Read; 2007 Jan; 17(1):7, 18. PubMed ID: 17274141
    [No Abstract]   [Full Text] [Related]  

  • 32. I will urge caution.
    Garcia B
    WORLD; 2000 Jan; (105):5. PubMed ID: 11851144
    [No Abstract]   [Full Text] [Related]  

  • 33. Retrovir efficacy supplement approved.
    AIDS Patient Care STDS; 2008 Nov; 22(11):918. PubMed ID: 19043841
    [No Abstract]   [Full Text] [Related]  

  • 34. Anti-HIV agents. Drug holidays.
    TreatmentUpdate; 2003; 15(5):3-4. PubMed ID: 17216856
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacokinetic variability of antiretroviral drugs and correlation with virological outcome: 2 years of experience in routine clinical practice.
    Fabbiani M; Di Giambenedetto S; Bracciale L; Bacarelli A; Ragazzoni E; Cauda R; Navarra P; De Luca A
    J Antimicrob Chemother; 2009 Jul; 64(1):109-17. PubMed ID: 19398461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A guide for understanding the guidelines.
    Sharp M
    Posit Aware; 2004; 15(1):43-5. PubMed ID: 14989197
    [No Abstract]   [Full Text] [Related]  

  • 37. Anti-HIV agents. Can valproic acid help flush HIV from hiding?
    TreatmentUpdate; 2005; 17(6):4-5. PubMed ID: 17228475
    [No Abstract]   [Full Text] [Related]  

  • 38. The current status of antiretroviral therapy in Africa.
    Bray DH
    J HIV Ther; 2006 Mar; 11(1):7-10. PubMed ID: 16706249
    [No Abstract]   [Full Text] [Related]  

  • 39. Key clinical trials of non-nucleoside reverse transcriptase inhibitors in the treatment of chronic HIV-1 infection in adults.
    Williams I
    J HIV Ther; 2008 Mar; 13(1):19-23. PubMed ID: 18953269
    [No Abstract]   [Full Text] [Related]  

  • 40. Antiretrovirals in the pipeline: anticipated updates.
    Laurence J
    AIDS Read; 2005 Nov; 15(11):577-8. PubMed ID: 16329178
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.